However, carriers of the GBA1 mutation exhibit earlier disease onset, reduced survival, greater family history, more severe and frequent motor symptoms (dyskinesias, dysphagia, dysarthria, freezing of gait) and non-motor symptoms (dementia, visual hallucinations, depression, anxiety, RBD, olfactory dysfunction) [87]. Here, GBA1 is linked to depressive symptom measurement.